NEWS

New Publication Announcement!

New Publication Announcement!

Branco et al. have recently published an excellent paper showing the benefits of Atelerix technology in the preservation of Adipose-Derived Mesenchymal Stromal Cells. Demonstrating the maintenance of MSC viability and...

New Publication Announcement!

Branco et al. have recently published an excellent paper showing the benefits of Atelerix technology in the preservation of Adipose-Derived Mesenchymal Stromal Cells. Demonstrating the maintenance of MSC viability and...

CytoStor™ & the transport of precious cells

CytoStor™ & the transport of precious cells

How preservation of urine can impact kidney disease research Background: Each day, 20 people in the UK alone, develop chronic kidney disease, while an estimated 3 million people in the...

CytoStor™ & the transport of precious cells

How preservation of urine can impact kidney disease research Background: Each day, 20 people in the UK alone, develop chronic kidney disease, while an estimated 3 million people in the...

TissueReady™ & Organoid Modelling

TissueReady™ & Organoid Modelling

Pancreatic cancer is one of the most aggressive and lethal solid tumours. Pancreatic ductal adenocarcinoma (PDAC) describes malignancies of the exocrine pancreatic tissue, that account for 90% of all pancreatic...

TissueReady™ & Organoid Modelling

Pancreatic cancer is one of the most aggressive and lethal solid tumours. Pancreatic ductal adenocarcinoma (PDAC) describes malignancies of the exocrine pancreatic tissue, that account for 90% of all pancreatic...

BeadReady™ & Bioprinting MSC Spheroids

BeadReady™ & Bioprinting MSC Spheroids

The population of haematopoietic stem cells (HSCs) found in our bone marrow are responsible for repopulating the body with all blood and immune cells throughout our lives. As we age,...

BeadReady™ & Bioprinting MSC Spheroids

The population of haematopoietic stem cells (HSCs) found in our bone marrow are responsible for repopulating the body with all blood and immune cells throughout our lives. As we age,...

Atelerix supports lifETIME CDT

Atelerix supports lifETIME CDT

The EPSRC-SFI Joint Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME CDT) is a partnership between the University of Glasgow, University of Birmingham, Aston University...

Atelerix supports lifETIME CDT

The EPSRC-SFI Joint Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME CDT) is a partnership between the University of Glasgow, University of Birmingham, Aston University...

Atelerix presents promising data for the application of its technology LeukoStor™ to CAR-T Cell Therapy Manufacturing

Atelerix presents promising data for the applic...

One of the biggest challenges faced by CAR-T Cell manufactures is the variability among apheresis product, which can negatively impact T Cell manufacturing success and therefore patient treatment. A solution...

Atelerix presents promising data for the applic...

One of the biggest challenges faced by CAR-T Cell manufactures is the variability among apheresis product, which can negatively impact T Cell manufacturing success and therefore patient treatment. A solution...